MedTrace Logo

RFA for Flat Type High-grade and Medium-grade Intraepithelial Squamous Neoplasia

NCT02953418 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2020-08-12

Study results available
· View outcomes & findings →

Summary

Multicenter, prospective cohort clinical trial in greater China

Conditions

  • Esophageal Squamous Cell Neoplasia (ESCN)

Interventions

DEVICE

Radiofrequency ablation

RFA

Sponsors & Collaborators

  • Medtronic - MITG

    lead INDUSTRY

Principal Investigators

  • Amanda Cafaro, RN · Medtronic Gastrointestinal & Hepatology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-20
Primary Completion
2019-07-20
Completion
2019-07-20
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02953418 on ClinicalTrials.gov